临床淋巴结阴性涎腺癌的处理:观察、颈淋巴结清扫还是颈部放疗?
该研究基于IRB批准的登记数据库,纳入445例临床淋巴结阴性(cN0)涎腺癌患者,按颈部处理方式分为观察组203例、颈淋巴结清扫(ND)组83例、颈部放疗(NI)组71例及ND+NI组88例。四组间局部复发(9.9%-16.7%,p=0.6)和区域复发(3.9%-9.4%,p=0.76)无显著差异,但5年远处复发率(观察7%、ND 16%、NI 25%、ND+NI 37%,p<0.001)和10年总生存率(观察78%、ND 66%、NI 69%、ND+NI 52%,p<0.001)存在显著差异。结论认为在适当选择的患者中ND与NI区域控制相似,高危患者ND+NI区域控制良好但远处转移是影响总生存的主要因素。
要点
- cN0涎腺癌观察、ND、NI及ND+NI四组间局部和区域复发无显著差异。
- 5年远处复发观察组7%、ND组16%、NI组25%、ND+NI组37%(p<0.001)。
- 10年总生存观察组78%、ND组66%、NI组69%、ND+NI组52%(p<0.001)。
核心结论
- 对于cN0涎腺癌患者,在适当选择的患者中颈淋巴结清扫和颈部放疗可获得相似的区域控制。
- 在高危且具有多项不良风险特征的患者中,颈淋巴结清扫联合颈部放疗可获得良好的区域控制,但远处转移是影响总生存的驱动因素。
研究设计与样本
- IRB批准的登记数据库查询研究,纳入cN0涎腺癌患者445例,按颈部处理方式分为观察组203例、颈淋巴结清扫组83例、颈部放疗组71例及颈淋巴结清扫联合颈部放疗组88例。
- cN0定义为无临床或影像学转移性淋巴结病变证据。
- 中位随访60.8个月(范围0.4-258)。
主要发现
- 临床T分期为T1者47%、T2者29%、T3和T4各12%;90%为cN0,10%有临界淋巴结特征。
- 大涎腺为最常见部位(74%),最常见组织学为黏液表皮样癌(28%)和腺样囊性癌(20%)。
- 与区域复发相关的风险因素包括年龄、临界淋巴结特征、病理T和N分期、低分化、切缘阳性、淋巴血管间隙侵犯和结外扩展(均p<0.05)。
- 四组间局部复发(9.9%-16.7%,p=0.6)和区域复发(3.9%-9.4%,p=0.76)无显著差异。
- 5年远处复发率观察组7%、颈淋巴结清扫组16%、颈部放疗组25%、颈淋巴结清扫联合颈部放疗组37%(p<0.001);10年总生存估计观察组78%、颈淋巴结清扫组66%、颈部放疗组69%、颈淋巴结清扫联合颈部放疗组52%(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Salivary gland malignancies are heterogeneous tumors with highly variable outcomes. Elective neck management options include observation, neck dissection (ND), and neck irradiation (NI). We sought to compare outcomes of cN0 salivary gland cancer by elective neck management. METHODS: An IRB-approved registry was queried for cN0 salivary gland cancers and categorized based on neck management into observation, ND, NI, and ND + NI groups. cN0 included no evidence of clinical or radiographic metastatic lymphadenopathy. RESULTS: A total of 445 patients were included with 203 in observation, 83 ND, 71 NI, and 88 ND + NI. Median follow-up was 60.8 months (range 0.4-258). There were 47% clinical T1 tumors, 29% T2, and 12% of each T3 and T4. Exactly 90% were cN0 and 10% with borderline lymph node(s). The major salivary gland was the most common site (74%) and the most common histologies included 28% mucoepidermoid and 20% adenoid cystic. Risk factors associated with regional recurrence include age, borderline lymph node features, pathologic T and N stage, poorly differentiated, positive margin, lymphovascular space invasion, and extranodal extension (all p < 0.05). There was no significant difference in local (9.9%-16.7%, p = 0.6) or regional (3.9%-9.4%, p = 0.76) recurrence between all four groups. Five-year distant recurrence was significantly different at 7% for observation, 16% in ND, 25% in NI, and 37% in ND + NI (p < 0.001). Ten-year OS estimates were 78% for observation, 66% for ND, 69% for NI, and 52% in ND + NI (p < 0.001). CONCLUSION: For patients with cN0 salivary gland cancer, ND and NI yield similar regional control in appropriately selected patients. In high-risk patients with several adverse risk features ND + NI results in favorable regional control but distant metastasis is a driving factor affecting overall survival.
引用
- Ilori EO, Woody NM, Hair BB, et al. Management of Clinically Node-Negative Salivary Gland Cancer: Observation, Neck Dissection, or Neck Irradiation? Head Neck. 2025. PMID: 39835356. doi:10.1002/hed.28079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。